Trial no.:
|
PACTR202307804038673 |
Date of Approval:
|
14/07/2023 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Achilles tenotomy versus Percutaneous Z-plasty tendon Achilles lengthening in the treatment of Idiopathic Clubfoot using Ponseti technique |
Official scientific title |
A randomized controlled clinical trial of Achilles tenotomy versus Percutaneous Z-plasty tendon Achilles lengthening in the treatment of Idiopathic Clubfoot using Ponseti technique- a Multicenter study |
Brief summary describing the background
and objectives of the trial
|
Ponseti techniques recommended the use of Achilles tenotomy to correct residual equinus before the final cast application. The success recorded with the Ponseti method of clubfoot treatment comes with reported cases of relapse during the follow-up period. The relapse rate in the long-term follow-up from the University of Iowa was 56%. However, a recent meta-analysis reported relapse rates ranging from 3.7% to 67%. (9–12) One of the major reasons for relapse in most studies was poor compliance with brace usage with higher rates recorded in those who used the brace for less than 2 years compared to those who wore theirs for up to 4 years. The earliest sign of relapse is heel varus; because percutaneous TAL can correct both equinus and varus deformity, it is thought that it could reduce relapse rates.
This study aims to compare the use of Achilles tenotomy with percutaneous TAL to correct residual equinus before final cast application in patients with idiopathic clubfoot using functional outcome, percentage of relapse, and percentage of those that will require secondary procedures at three tertiary health institution in South western, Nigeria. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Musculoskeletal Diseases,Orthopaedics,Paediatrics,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Surgery |
Anticipated trial start date |
07/11/2023 |
Actual trial start date |
01/04/2024 |
Anticipated date of last follow up |
17/11/2025 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
102 |
Actual target sample size (number of participants) |
|
Recruitment status |
Recruiting |
Publication URL |
|
|